N/A
Completed N=933
Educating Nurses About Venous Thromboembolism (VTE) Prevention
Source: ClinicalTrials.gov NCT02301793 ↗Enrolled (actual)
933
Serious AEs
0.0%
Results posted
May 2019
Primary outcomePrimary: Non Administration of Prescribed VTE Prophylaxis Medication Doses — 10.8; 14.5; 9.2; 13.5 percentage of nonadministration — p=0.05
Summary
As part of mandatory on-going nursing education, the investigators have incorporated identical information into two distinct web-based learning formats - the traditional linear PowerPoint format (with voice-over) and a new interactive format developed with central nursing education.
The investigators will cluster randomize nurses by floor to receive either the traditional education or the new interactive education, and evaluate the impact on administration of VTE prophylaxis doses administered by nurses before and after education. All nurses on a floor will receive the same educational format. If one method of education results in statistically significant improvement in VTE prophylaxis administration, the investigators will cross over to deliver the superior education format to all nurses who originally were given the less effective method.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Non Administration of Prescribed VTE Prophylaxis Medication Doses |
10.8; 14.5; 9.2; 13.5 | 0.05 |
| SECONDARY Rates of All VTE Among Hospitalized Patients |
— | — |
| SECONDARY Rates of Deep Vein Thrombosis (DVT) Among Hospitalized Patients |
— | — |
| SECONDARY Rates of Pulmonary Embolism (PE) Among Hospitalized Patients |
— | — |
| SECONDARY Proportion of Non Administration of Prescribed VTE Prophylaxis Medication Doses Which Are Documented as Patient Refusal |
5.6; 7.3; 5.1; 7.0 | 0.05 |
Eligibility Criteria
Inclusion Criteria
- Nurses on selected surgical and medical floors at Johns Hopkins Hospital
Exclusion Criteria
- Nurses who were not permanently associated with one of the 21 hospital floors (e.g. traveling nurse, float nurse) were excluded from this study
Data sourced from ClinicalTrials.gov (NCT02301793). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.